Low density lipoprotein cholesterol level inversely correlated with coronary flow velocity reserve in patients with Type 2 diabetes

Journal of Geriatric Cardiology

Volumn 10, Issue 2, 2013, Pages 159-164

  Yu, Jie ^a,b   Han, Jiang Li ^a,b   He, Li Yun ^a,b   Feng, Xin Heng ^a,b   Li, Wei Hong ^a,b   Mao, Jie Ming ^a,b   Gao, Wei ^a,b   Wang, Guang ^c  

^a PEKING UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Coronary flow velocity reserve; Diabetes mellitus; Endothelial function; High density lipoprotein cholesterol; Low density lipoprotein cholesterol

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY FLOW RESERVE; DIABETIC PATIENT; DIET RESTRICTION; DOPPLER ECHOCARDIOGRAPHY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; HYPERTENSION; INSULIN BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84883285447     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.02.007     Document Type: Article

References (23)

1. Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567-574. (Pubitemid 26081917)
2. Nitenberg A, Valensi P, Sachs R, et al. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with ahgiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993; 42: 1017-1025. (Pubitemid 23182168)
3. Dart AM, Chin-Dusting JPF. Lipids and the endothelium. Cardiovasc Res; 1999; 43: 308-322. (Pubitemid 29356369)
4. Sheu WHH, ChenYT, Lee WJ. Imprivement in endothelial dysfunction with LDL cholesterol level < 80 mg/dL in type 2 diabetes mellites. Diabetes Care 2001; 24: 1499-1501.
5. Ashen MD, Blumenthal RS. Clinical practice: low HDL cholesterol levels. N Engl J Med 2005; 353: 1252-1260. (Pubitemid 41345947)
6. Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357: 1301-1310. (Pubitemid 47481452)
7. Persegol L, Verges B, Foissac M, et al. Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia 2006; 49: 1380-1386.
8. Bartel T, Yang Y, Muller S, et al. Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. J Am Coll Cardiol 2002; 39: 2012-2018. (Pubitemid 34628284)
9. Hozumi T, Yoshida K, Ogata Y, et al. Noninvasive assessment of significant left anterior coronary descending artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97: 1557-1562. (Pubitemid 28186183)
10. Logstrup BB, Hofsten DE, Christophersen TB, et al. Influence of abnormal glucose metabolism on coronary microvascular function after a recent myocardial infarction. J Am Coll Cardiol 2009; 2: 1159-1166.
11. Cortigiani L, Rigo F, Gherardi S, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007; 50: 1354-1361. (Pubitemid 47449732)
12. He L, Zeng H, Li F, et al. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobipterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab 2010; 299: E1061-E1065.
13. Campisis R, Di Carli MF. Assessment of coronary flow reserve and microcirculation: a critical perspective. J Nucl Cardiol 2004; 11: 3-11. (Pubitemid 38219563)
14. Lupi A, Buffon A, Finocchiaro ML, et al. Mechanisms of adenosine-induced epicardial coronary dilatation. Eur Heart J 1997; 18: 614-617. (Pubitemid 27182354)
15. Yokoyama I, Ohtake T, Momomura S, et al. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996; 94: 3232-3238. (Pubitemid 26427492)
16. Hein WH, Kuo L. LDLs impair vasomotor function of the coronary microcirculation: role of superoxide anions. Circ Res 1998; 83: 404-414. (Pubitemid 28389970)
17. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.
18. Kaufmann P, Gnecchi-Ruscone T, Schafers KP, et al. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000; 36: 103-109. (Pubitemid 30466119)
19. Nofer JR, van der Giet M, Tolle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004; 113: 569-581. (Pubitemid 38542506)
20. Spieker LE, Sudano I, Hurlimann D, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002; 105: 1399-1402. (Pubitemid 34263266)
21. Ansell BJ, Navab M, Hama S, et al. Inflammatory/anti-inflammatory properties of high-density lipoprotein distinguish patients from Non-DM subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 2003; 108: 2751-2756. (Pubitemid 37498976)
22. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-2122. (Pubitemid 350146106)
23. Sorrentino SA, Besler C, Rohrer L, et al. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2010; 121: 110-122.